Literature DB >> 20372864

Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells.

Feng Chen1, Hai-Hong Zhu, Lin-Fu Zhou, Shan-Shan Wu, Jing Wang, Zhi Chen.   

Abstract

Dysregulation of the antiapoptotic protein cellular FLICE-like inhibitory protein (c-FLIP) has been proven to be associated with tumorigenesis and progress of most human cancers. However, its aberrant expression is poorly elucidated. MicroRNAs (miRNAs) are small non-coding RNAs that are involved in tumorigenesis through negatively regulating gene expression. Our study disclosed that c-FLIP was overexpressed in HepG2 hepatocellular carcinoma cells and down-regulation of c-FLIP enhanced taxol-induced apoptosis. Taxol induction significantly decreased the protein level of c-FLIP. While no decrease in c-FLIP mRNA level was observed, indicating taxol decreased c-FLIP expression through a post-transcriptional mechanism. miR-512-3p was a predicted suppressor of c-FLIP and exhibited an opposite expression manner to c-FLIP before and after taxol induction. Luciferase report assay demonstrated miR-512-3p negatively regulated c-FLIP expression via a conserved miRNA-binding site in 3' untranslated region (3'UTR) of c-FLIP. The decrease of c-FLIP protein due to transfection of miR-512-3p further validated the inhibitory effect of miR-512-3p on c-FLIP. Additional transfection of miR-512-3p remarkably promoted taxol-induced apoptosis, confirming its involvement in apoptosis. In summary, our study disclosed a novel regulatory mechanism that down-regulation of c-FLIP by miR-512-3p contributed to taxol-induced apoptosis. Importantly, the pivotal role of miR-512-3p in determining c-FLIP abundance helps to broaden the implications for cancer therapy by developing small molecules to directly target c-FLIP at mRNA level.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372864     DOI: 10.3892/or_00000784

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  32 in total

Review 1.  Causes and consequences of microRNA dysregulation.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

2.  In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by taxol.

Authors:  V G Minero; D De Stefanis; P Costelli; F M Baccino; G Bonelli
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival.

Authors:  K R Delfino; N V L Serão; B R Southey; S L Rodriguez-Zas
Journal:  Cancer Genomics Proteomics       Date:  2011 Jul-Aug       Impact factor: 4.069

4.  MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer.

Authors:  Roland Hubaux; Daiana D Becker-Santos; Katey S S Enfield; Stephen Lam; Wan L Lam; Victor D Martinez
Journal:  Metabolomics (Los Angel)       Date:  2012-03-21

Review 5.  Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.

Authors:  Andrea L Kasinski; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2011-11-24       Impact factor: 60.716

6.  The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells.

Authors:  Lyndsay V Rhodes; Ashley M Nitschke; H Chris Segar; Elizabeth C Martin; Jennifer L Driver; Steven Elliott; Seung Yoon Nam; Meng Li; Kenneth P Nephew; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Oncol Rep       Date:  2011-10-04       Impact factor: 3.906

Review 7.  microRNA involvement in human cancer.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  Carcinogenesis       Date:  2012-04-03       Impact factor: 4.944

Review 8.  Resistance to Cell Death and Its Modulation in Cancer Stem Cells.

Authors:  Ahmad R Safa
Journal:  Crit Rev Oncog       Date:  2016

9.  miR-125b suppresses cellular proliferation by targeting c-FLIP in gallbladder carcinoma.

Authors:  Huajie Zong; Huading Zhou; Yang Xiang; Gang Wu
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

Review 10.  MicroRNAs as therapeutic targets in chemoresistance.

Authors:  Michela Garofalo; Carlo M Croce
Journal:  Drug Resist Updat       Date:  2013-06-10       Impact factor: 18.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.